Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cetus Capital II Reports New Position in Luxfer Holdings

Cetus Capital II, LLC has reported opening a position in Luxfer Holdings PLC (ADR) (NYSE:LXFR). In a recent filing with the Securities and Exchange Commission, Cetus Capital revealed the acquisition of 874,133 shares, which represent 6.5% of Luxfer Holdings’s common stock .

Another hedge fund that likes Luxfer Holdings is Marathon Asset Management, run by Bruce J. Richards and Louis Hanover. In the latest 13F filing with the SEC, Marathon also disclosed a new position in Luxfer Holdings. The fund acquired 2.1 million shares with a reported value of $31.7 million. Jonathan Savitz‘s Greywolf Capital Management is also confident in the financial performance of Luxfer, having reported in the most recent 13F filing no change to the fund’s investment in the company. Greywolf Capital holds 1.3 million shares with reportedly worth $21.5 million. Eric Edidin and Josh Lobel‘s Archer Capital Management have also taken their chances and opened a new position. The fund reported owning 751K shares valued at a little over $12 million.

A manufacturer of gas containment cylinders, Luxfer Holdings’ shares have been in an uptrend, rising 42 % in 2013 to a current price of $17.9. The stock has a trailing Price to Earnings (P/E) ratio of 12.82 and pays a dividend of $0.4 per share, which represents a yield of 2.2%. The company recently announced financial results for the third quarter of 2013. Luxfer Holdings registered net revenues of $9.3 million, a 7.9% year over year decline, and earnings per American Depositary Share of $0.33 failing to meet the expected $0.35 per share. Nevertheless, the stock is still highly regarded by analysts, who recommend it mainly as a Strong Buy. The share prices are expected to rise, with experts having set a mean target of $20.25.

Disclosure: none

Recommended reading:

Eric Bannasch, Cadian Capital Add to Position in Green Plains Renewable Energy

Barry Rosenstein, Jana Partners Cut Their Stake in Oil States International

Starboard Value, Elliott Associates Sell Shares of Emulex Corporation

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!